PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease
暂无分享,去创建一个
Cheryl F. Lichti | Norelle C. Wildburger | Fernanda Laezza | Rovshan G. Sadygov | G. Taglialatela | R. Sadygov | A. Singh | L. Denner | K. Dineley | S. Haidacher | F. Laezza | M. Nenov | Wei-Chun J. Hsu | Sigmund J. Haidacher | Miroslav N. Nenov | Oluwarotimi Folorunso | Aditya K. Singh | Brent C. Chesson | Whitney F. Franklin | Ibdanelo Cortez | Kelly T. Dineley | Jay S. Rudra | Giulio Taglialatela | Larry Denner | Oluwarotimi O. Folorunso | Ibdanelo Cortez | Whitney Franklin | J. Rudra | W. Hsu
[1] M. Mobashir,et al. Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease. , 2016, European journal of medicinal chemistry.
[2] S. Stoilova-McPhie,et al. Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex. , 2012, Assay and drug development technologies.
[3] H. Manji,et al. AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. , 2004, The international journal of neuropsychopharmacology.
[4] B. Penninx,et al. A Fine-Mapping Study of 7 Top Scoring Genes from a GWAS for Major Depressive Disorder , 2012, PloS one.
[5] J. del Río,et al. Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model. , 2009, Biochemical and biophysical research communications.
[6] E. ter Haar,et al. Structure of GSK3beta reveals a primed phosphorylation mechanism. , 2001, Nature structural biology.
[7] Je-Hyun Baek,et al. Reciprocal Changes in Phosphorylation and Methylation of Mammalian Brain Sodium Channels in Response to Seizures* , 2014, The Journal of Biological Chemistry.
[8] A. García-Osta,et al. Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology , 2010, Neuropsychopharmacology.
[9] G. Abecasis,et al. Fine Mapping on Chromosome 13q32–34 and Brain Expression Analysis Implicates MYO16 in Schizophrenia , 2014, Neuropsychopharmacology.
[10] K. Hsu,et al. Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways , 2011, Neuropharmacology.
[11] H. Manji,et al. AR-A 014418 , a selective GSK-3 inhibitor , produces antidepressant-like effects in the forced swim test , 2004 .
[12] Norelle C. Wildburger,et al. Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase , 2012, Front. Mol. Neurosci..
[13] I. Torres-Aleman,et al. Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury , 2014, F1000Research.
[14] H. Hanyu,et al. Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease , 2011, Neurobiology of Aging.
[15] S. Michnick,et al. A highly sensitive protein-protein interaction assay based on Gaussia luciferase , 2006, Nature Methods.
[16] G. Terstappen,et al. Therapeutic targets for Alzheimer's disease , 2009, Expert opinion on therapeutic targets.
[17] G. Landreth,et al. Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease , 2012, The Journal of Neuroscience.
[18] M. Mohammadi,et al. Crystal Structure of a Fibroblast Growth Factor Homologous Factor (FHF) Defines a Conserved Surface on FHFs for Binding and Modulation of Voltage-gated Sodium Channels* , 2009, The Journal of Biological Chemistry.
[19] Syed R Ali,et al. Identification of Amino Acid Residues in Fibroblast Growth Factor 14 (FGF14) Required for Structure-Function Interactions with Voltage-gated Sodium Channel Nav1.6* , 2016, The Journal of Biological Chemistry.
[20] W. Honer,et al. Linkage of familial schizophrenia to chromosome 13q32. , 1999, American journal of human genetics.
[21] G. Aghajanian,et al. GSK-3 Inhibition Potentiates the Synaptogenic and Antidepressant-Like Effects of Subthreshold Doses of Ketamine , 2013, Neuropsychopharmacology.
[22] Lin Xu,et al. Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14 , 2007, Molecular and Cellular Neuroscience.
[23] M. Grubb,et al. Building and maintaining the axon initial segment , 2010, Current Opinion in Neurobiology.
[24] J. Nerbonne,et al. FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels , 2009, Molecular and Cellular Neuroscience.
[25] W. Harrington,et al. The Effect of PPARα, PPARδ, PPARγ, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice , 2007, PPAR research.
[26] J. O'Donnell,et al. Phosphodiesterase-4D Knock-Out and RNA Interference-Mediated Knock-Down Enhance Memory and Increase Hippocampal Neurogenesis via Increased cAMP Signaling , 2011, The Journal of Neuroscience.
[27] N. Ip,et al. Scapinin-induced Inhibition of Axon Elongation Is Attenuated by Phosphorylation and Translocation to the Cytoplasm , 2011, The Journal of Biological Chemistry.
[28] R. Sadygov,et al. Detection of structural and metabolic changes in traumatically injured hippocampus by quantitative differential proteomics. , 2013, Journal of neurotrauma.
[29] E. Emamian. AKT/GSK3 signaling pathway and schizophrenia , 2012, Front. Mol. Neurosci..
[30] Paul M. Thompson,et al. Detecting genetic risk factors for Alzheimer's disease in whole genome sequence data via Lasso screening , 2015, 2015 IEEE 12th International Symposium on Biomedical Imaging (ISBI).
[31] G. Wilcock,et al. The cholinergic hypothesis of Alzheimer’s disease: a review of progress , 1999, Journal of neurology, neurosurgery, and psychiatry.
[32] S. Lane,et al. PPARγ agonism attenuates cocaine cue reactivity , 2018, Addiction biology.
[33] F. Duffy,et al. Copy number variation plays an important role in clinical epilepsy , 2014, Annals of neurology.
[34] J. Nerbonne,et al. The FGF14F145S Mutation Disrupts the Interaction of FGF14 with Voltage-Gated Na+ Channels and Impairs Neuronal Excitability , 2007, The Journal of Neuroscience.
[35] D. Wozniak,et al. Impaired spatial learning and defective theta burst induced LTP in mice lacking fibroblast growth factor 14 , 2007, Neurobiology of Disease.
[36] J. Radulovic,et al. The role of hippocampal signaling cascades in consolidation of fear memory , 2004, Behavioural Brain Research.
[37] F. Laezza,et al. Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K+ current inhibition mediated by activation of caspases and GSK-3 , 2015, Neurobiology of Aging.
[38] L. Denner,et al. Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status , 2011, Behavioural Brain Research.
[39] D. Wozniak,et al. Ataxia and Paroxysmal Dyskinesia in Mice Lacking Axonally Transported FGF14 , 2002, Neuron.
[40] R. Sadygov,et al. Cognitive Enhancing Treatment with a PPARγ Agonist Normalizes Dentate Granule Cell Presynaptic Function in Tg2576 APP Mice , 2014, The Journal of Neuroscience.
[41] G. Taglialatela,et al. A method to determine insulin responsiveness in synaptosomes isolated from frozen brain tissue , 2016, Journal of Neuroscience Methods.
[42] J. Nerbonne,et al. FGF14 localization and organization of the axon initial segment , 2013, Molecular and Cellular Neuroscience.
[43] M. Reger,et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[44] O. Andersen,et al. Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery , 2011, The Journal of general physiology.
[45] Rovshan G Sadygov,et al. Using power spectrum analysis to evaluate (18)O-water labeling data acquired from low resolution mass spectrometers. , 2010, Journal of proteome research.
[46] D. Chuang,et al. Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice. , 2011, The international journal of neuropsychopharmacology.
[47] J. David Sweatt,et al. The MAPK cascade is required for mammalian associative learning , 1998, Nature Neuroscience.
[48] E. Koroś,et al. The role of glycogen synthase kinase-3beta in schizophrenia. , 2007, Drug news & perspectives.
[49] M. Mann,et al. Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.
[50] J. A. Nogueira-Machado,et al. Rosiglitazone, a PPAR-γ agonist, inhibits VEGF secretion by peripheral blood mononuclear cells and ROS production by human leukocytes , 2011, Inflammation Research.
[51] Neli I Panova-Elektronova,et al. Parallel fiber to Purkinje cell synaptic impairment in a mouse model of spinocerebellar ataxia type 27 , 2015, Front. Cell. Neurosci..
[52] P. Blandina,et al. Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse , 2016, Neuropharmacology.
[53] Elmar Krieger,et al. A Mutation in the Fibroblast Growth Factor 14 Gene Is Associated with Autosomal Dominant Cerebral Ataxia , 2003 .
[54] P. Heutink,et al. Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): A new phenotype , 2006, Movement disorders : official journal of the Movement Disorder Society.
[55] Arturo Pujia,et al. Possible implications of insulin resistance and glucose metabolism in Alzheimer’s disease pathogenesis , 2011, Journal of cellular and molecular medicine.
[56] A. Gingras,et al. Systematic investigation of hierarchical phosphorylation by protein kinase CK2. , 2015, Journal of proteomics.
[57] Christoph W. Blau,et al. Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP , 2012, Neurobiology of Aging.
[58] M. Oellerich,et al. Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer’s disease patients , 2012, Journal of neurochemistry.
[59] K. Kwong,et al. Voltage-gated sodium channels. , 2015, Current opinion in pharmacology.
[60] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[61] C. Landry,et al. A toolkit of protein-fragment complementation assays for studying and dissecting large-scale and dynamic protein-protein interactions in living cells. , 2010, Methods in enzymology.
[62] Amanda J. Foust,et al. The spatio‐temporal characteristics of action potential initiation in layer 5 pyramidal neurons: a voltage imaging study , 2011, The Journal of physiology.
[63] Alexandre P. Blanchard,et al. Phosphoproteome analysis of an early onset mouse model (TgCRND8) of Alzheimer's disease reveals temporal changes in neuronal and glia signaling pathways , 2013, Proteomics.
[64] D. Ornitz,et al. Subcellular and developmental expression of alternatively spliced forms of fibroblast growth factor 14 , 2000, Mechanisms of Development.
[65] R. Sadygov,et al. Cognitive Enhancement with Rosiglitazone Links the Hippocampal PPARγ and ERK MAPK Signaling Pathways , 2012, The Journal of Neuroscience.
[66] J. Nerbonne,et al. Fibroblast growth factor 14 is an intracellular modulator of voltage‐gated sodium channels , 2005, The Journal of physiology.
[67] C. Ruivenkamp,et al. A new variable phenotype in spinocerebellar ataxia 27 (SCA 27) caused by a deletion in the FGF14 gene. , 2014, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[68] Jesús Avila,et al. Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors , 2010, Expert review of neurotherapeutics.
[69] F. Tempia,et al. Impaired Firing Properties of Dentate Granule Neurons in an Alzheimer's Disease Animal Model Are Rescued by Ppar␥ Agonism , 2022 .
[70] C. Nilsson,et al. Role of the Axonal Initial Segment in Psychiatric Disorders: Function, Dysfunction, and Intervention , 2014, Front. Psychiatry.
[71] M. Roh,et al. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions. , 2006, Current drug targets.
[72] E. Hoxha,et al. Genetic deletion of fibroblast growth factor 14 recapitulates phenotypic alterations underlying cognitive impairment associated with schizophrenia , 2016, Translational psychiatry.
[73] David Piwnica-Worms,et al. Current state of imaging protein-protein interactions in vivo with genetically encoded reporters. , 2007, Annual review of biomedical engineering.
[74] Elmar Krieger,et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. , 2003, American journal of human genetics.
[75] Suzanne R. Kalb,et al. Assembly Protein Precursor (pUL80.5 Homolog) of Simian Cytomegalovirus Is Phosphorylated at a Glycogen Synthase Kinase 3 Site and Its Downstream “Priming” Site: Phosphorylation Affects Interactions of Protein with Itself and with Major Capsid Protein , 2004, Journal of Virology.
[76] Richard D. LeDuc,et al. Quantitative Proteomics Reveals Protein–Protein Interactions with Fibroblast Growth Factor 12 as a Component of the Voltage-Gated Sodium Channel 1.2 (Nav1.2) Macromolecular Complex in Mammalian Brain , 2015, Molecular & Cellular Proteomics.
[77] L. Swenson,et al. Structure of GSK3β reveals a primed phosphorylation mechanism , 2001, Nature Structural Biology.
[78] David B. Goldstein,et al. A Genome-Wide Investigation of SNPs and CNVs in Schizophrenia , 2009, PLoS genetics.
[79] J. Sweatt,et al. Mitogen-activated protein kinases in synaptic plasticity and memory , 2004, Current Opinion in Neurobiology.
[80] William A Catterall,et al. Voltage‐gated sodium channels at 60: structure, function and pathophysiology , 2012, The Journal of physiology.
[81] A. De Luca,et al. Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery , 2016, Front. Pharmacol..
[82] M. Pérez,et al. Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease , 2015, PPAR research.
[83] I. Torres-Aleman,et al. Astrocytes require insulin-like growth factor I to protect neurons against oxidative injury. , 2014, F1000Research.
[84] Norelle C. Wildburger,et al. The Fibroblast Growth Factor 14·Voltage-gated Sodium Channel Complex Is a New Target of Glycogen Synthase Kinase 3 (GSK3)* , 2013, The Journal of Biological Chemistry.
[85] G. Breen,et al. Linkage Replication for Chromosomal Region 13q32 in Schizophrenia: Evidence from a Brazilian Pilot Study on Early Onset Schizophrenia Families , 2012, PloS one.
[86] I. Gaisina,et al. Glycogen Synthase Kinase-3 Is a Functional Modulator of Serotonin-1 B Receptors , 2011 .
[87] Zayd M. Khaliq,et al. Relative Contributions of Axonal and Somatic Na Channels to Action Potential Initiation in Cerebellar Purkinje Neurons , 2006, The Journal of Neuroscience.
[88] S. Zaitone,et al. Pioglitazone and exenatide enhance cognition and downregulate hippocampal beta amyloid oligomer and microglia expression in insulin-resistant rats. , 2016, Canadian journal of physiology and pharmacology.
[89] C. Ong,et al. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway. , 2010, Cancer letters.
[90] F. Laezza,et al. Fibroblast Growth Factor 14 Modulates the Neurogenesis of Granule Neurons in the Adult Dentate Gyrus , 2016, Molecular Neurobiology.
[91] J. Trimmer,et al. Multisite phosphorylation of voltage-gated sodium channel alpha subunits from rat brain. , 2010, Journal of proteome research.
[92] Mert R. Sabuncu,et al. Machine Learning and Medical Imaging , 2016 .
[93] Shaun P Jackson,et al. Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling. , 2007, The Biochemical journal.
[94] M. Berk,et al. The Putative Use of Lithium in Alzheimer's Disease. , 2016, Current Alzheimer research.
[95] F. Laezza,et al. Intracellular Fibroblast Growth Factor 14: Emerging Risk Factor for Brain Disorders , 2017, Front. Cell. Neurosci..
[96] F. Laezza,et al. Improved Methods for Fluorescence Microscopy Detection of Macromolecules at the Axon Initial Segment , 2016, Front. Cell. Neurosci..
[97] D. Piwnica-Worms,et al. Detection of protein-protein interactions in live cells and animals with split firefly luciferase protein fragment complementation. , 2008, Methods in molecular biology.
[98] J. D. McGaugh. Memory--a century of consolidation. , 2000, Science.
[99] Shao Li,et al. Elevated Neuronal Excitability Due to Modulation of the Voltage-Gated Sodium Channel Nav1.6 by Aβ1−42 , 2016, Front. Neurosci..
[100] V. Bennett,et al. Physiological roles of axonal ankyrins in survival of premyelinated axons and localization of voltage-gated sodium channels , 1999, Journal of neurocytology.
[101] Manuela G. López,et al. Involvement of PI3K, GSK-3β and PPARγ in the antidepressant-like effect of folic acid in the forced swimming test in mice , 2012, Journal of psychopharmacology.
[102] R. Jope,et al. Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and Therapeutics , 2007, Neurochemical Research.
[103] Amanda J. Foust,et al. Action Potentials Initiate in the Axon Initial Segment and Propagate through Axon Collaterals Reliably in Cerebellar Purkinje Neurons , 2010, The Journal of Neuroscience.
[104] I. Módy,et al. Rosiglitazone prevents the memory deficits induced by amyloid-beta oligomers via inhibition of inflammatory responses , 2014, Neuroscience Letters.
[105] C. Matute. Astrocytes require insulin-like growth factor I to protect neurons , 2019 .
[106] Fernanda Laezza,et al. Split-luciferase complementation assay to detect channel-protein interactions in live cells. , 2015, Methods in molecular biology.
[107] Cheryl F. Lichti,et al. CK2 activity is required for the interaction of FGF14 with voltage‐gated sodium channels and neuronal excitability , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[108] W. Snider,et al. Functions of GSK-3 Signaling in Development of the Nervous System , 2011, Front. Mol. Neurosci..
[109] Hu-qing Wang,et al. The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus , 2012, Neurological Sciences.
[110] Joseph L. Ransdell,et al. Intracellular FGF14 (iFGF14) Is Required for Spontaneous and Evoked Firing in Cerebellar Purkinje Neurons and for Motor Coordination and Balance , 2015, The Journal of Neuroscience.
[111] Cheryl F. Lichti,et al. The Nav1.2 channel is regulated by GSK3. , 2015, Biochimica et biophysica acta.
[112] M. Zhan,et al. Identifying a Kinase Network Regulating FGF14:Nav1.6 Complex Assembly Using Split-Luciferase Complementation , 2015, PloS one.
[113] L. Denner,et al. PPARγ Recruitment to Active ERK during Memory Consolidation Is Required for Alzheimer's Disease-Related Cognitive Enhancement , 2014, The Journal of Neuroscience.
[114] Michael H. F. Wilkinson,et al. Digital Image Analysis of Microbes: Imaging, Morphometry, Fluorometry, and Motility Techniques and Applications , 1998 .
[115] Christophe Leterrier,et al. Protein kinase CK2 contributes to the organization of sodium channels in axonal membranes by regulating their interactions with ankyrin G , 2008, The Journal of cell biology.
[116] J. Trimmer,et al. Mass spectrometry-based phosphoproteomics reveals multisite phosphorylation on mammalian brain voltage-gated sodium and potassium channels. , 2011, Seminars in cell & developmental biology.
[117] Syed R Ali,et al. Modulation of the FGF14:FGF14 homodimer interaction through short peptide fragments. , 2014, CNS & neurological disorders drug targets.
[118] A D Roses,et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease , 2006, The Pharmacogenomics Journal.